ProQR Therapeutics reported revenue of $0.01B and net income of -$0.01B for the quarter ended Jun 2026, up 135.6% year over year. This income statement covers 52 quarters of results from Dec 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2012 | Sep2013 | Dec2013 | Mar2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.00B | 0.01B | ||||||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Amortization - Intangibles | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | -0.01B | -0.01B | -0.02B | -0.01B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | ||||||||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.00B | -0.00B | -0.00B | -0.01B | ||||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | ||||||||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| EBIT | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.01B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | |||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| EBT | -0.02B | -0.02B | -0.02B | -0.01B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| Tax ProvisionsTaxes | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | 0.02B | -0.02B | -0.02B | 0.01B | 0.02B | -0.12B | 0.01B | 0.01B | 0.01B | -0.05B | -0.01B | -0.00B | 0.01B | -0.05B | 0.01B | -0.01B | 0.01B | -0.09B | 0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| Equity Income | -0.00B | -0.00B | -0.00B | |||||||||||||||||||||||||||||||||||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -0.02B | -0.02B | -0.02B | -0.01B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -0.02B | -0.02B | -0.02B | -0.01B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -0.02B | -0.02B | -0.02B | -0.01B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -0.02B | -0.02B | -0.02B | -0.01B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.35 | -0.32 | -0.25 | -0.23 | -0.37 | -0.19 | -0.13 | -0.12 | -0.09 | -0.07 | -0.10 | -0.04 | -0.11 | -0.12 | -0.12 | -0.16 | -0.15 | -0.10 | -0.15 | -0.10 | ||||||||||||||||||||||||||||||||
| EPS (Diluted) | -0.19 | -0.13 | -0.12 | -0.09 | -0.07 | -0.10 | -0.04 | -0.11 | -0.12 | -0.12 | -0.16 | -0.15 | -0.10 | -0.15 | -0.10 | |||||||||||||||||||||||||||||||||||||
| Shares Outstanding | 0.05B | 0.06B | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B | 0.07B | 0.07B | 0.08B | 0.08B | 0.08B | 0.08B | 0.09B | 0.09B | 0.09B | 0.09B | 0.11B | 0.11B | 0.11B | ||||||||||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.07B | 0.07B | 0.07B | 0.07B | 0.08B | 0.08B | 0.08B | 0.08B | 0.09B | 0.09B | 0.09B | 0.09B | 0.11B | 0.11B | 0.11B | |||||||||||||||||||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.07B | 0.08B | 0.08B | 0.09B | 0.11B | |||||||||||||||||||||||||||||||||||||||||||||||
| EBITDA | -0.02B | -0.02B | -0.02B | -0.02B | -0.02B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.00B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.01B | -0.02B | -0.01B | ||||||||||||||||||||||||||||||||
| Interest ExpensesInt Expense | 0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.01B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | |||||||||||||||||||||||||||||||||
| Tax Rate | 0.23% | 0.12% | 0.05% | 0.15% | 0.30% | -1.44% | -0.52% | 0.75% | -0.09% | 0.04% | -6.92% | 4.23% | 0.15% | -0.41% | 0.29% |